Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06021769 · ClinicalTrials.gov registry record

Pessary Experience Study

A clinical trial of Pelvic Organ Prolapse and Stress Urinary Incontinence, sponsored by University of Virginia.

Recruiting
Registry status
30
Enrollment target
1
Study location

NCT06021769 is a study of Pelvic Organ Prolapse and Stress Urinary Incontinence that is actively recruiting participants, run by University of Virginia. The registered enrollment target is 30 participants, below the 144-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06021769, a study of Pelvic Organ Prolapse and Stress Urinary Incontinence, is actively recruiting participants, sponsored by University of Virginia.

RECRUITING
Registry status
30 participants
Enrollment target
1
Study location

Study Summary

Pessaries are silicone devices inserted into the vagina for treatment of pelvic organ prolapse or stress urinary incontinence. They are adequate treatment options for patients who are poor surgical candidates, those who decline surgical intervention, or as a temporizing measure in those ultimately planning surgery. Most studies suggest that about 75% of patients are able to be successfully fit with a pessary, but about 50% discontinue pessary use within 12 months of initiation. The purpose of this study is to determine why pessaries are discontinued.

Interventions

  • OTHER Observational only

Study Locations (1)

Virginia

  • University of Virginia - Charlottesville

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2023-06-12
Est. Completion 2026-12

Sponsor

University of Virginia

449 total trials

What the Registry Record Tells You About NCT06021769

The ClinicalTrials.gov registry entry for NCT06021769 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 144-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (79% lower). The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pelvic Organ Prolapse appearing as the primary indexed condition, and to 1 intervention - of which Observational only is the first listed.

NCT06021769 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT06021769 about?

NCT06021769 is a clinical study titled "Pessary Experience Study". Pessaries are silicone devices inserted into the vagina for treatment of pelvic organ prolapse or stress urinary incontinence. They are adequate treatment options for patients who are poor surgical candidates, those who decline surgical intervention, or as a temporizing measure in those ultimately p...

What is the current status of trial NCT06021769?

This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2023-06-12. Estimated completion is 2026-12.

What conditions does trial NCT06021769 study?

This clinical trial studies the following conditions: Pelvic Organ Prolapse, Stress Urinary Incontinence.

What interventions are being tested in trial NCT06021769?

The interventions under investigation include: Observational only (OTHER).

Who is sponsoring clinical trial NCT06021769?

This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06021769 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pelvic Organ Prolapse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.